EP Patent

EP3563842A1 — Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2019-11-06 · 7y expired

What this patent protects

The present invention relates to, inter alia , pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. In particular, the cardiovascular agent is a statin such as ros…

USPTO Abstract

The present invention relates to, inter alia , pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. In particular, the cardiovascular agent is a statin such as rosuvastatin.

Drugs covered by this patent

Patent Metadata

Patent number
EP3563842A1
Jurisdiction
EP
Classification
—
Expires
2019-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.